CSID

AlertMedia Appoints Marc Ostryniec as Chief Revenue Officer

Retrieved on: 
Wednesday, November 29, 2023
Software, Technology, Security, BIGC, Sale, Acquisition, Organization, Head, BigCommerce, Tata Consultancy Services, Culture, Intelligence, CSID, Trilogy, Bazaarvoice, Experian

AlertMedia , the world’s leading threat intelligence, emergency communication, and travel risk management provider, today announced it has hired Marc Ostryniec as its Chief Revenue Officer.

Key Points: 
  • AlertMedia , the world’s leading threat intelligence, emergency communication, and travel risk management provider, today announced it has hired Marc Ostryniec as its Chief Revenue Officer.
  • As CRO, Ostryniec will lead all aspects of AlertMedia’s global sales organization, including go-to-market strategy, channel partnerships, and personnel development to support AlertMedia’s continued momentum and rapidly growing customer base.
  • “Marc shares our belief that the world’s best companies are those that build great products along with great teams, which was one of many reasons that he was a clear choice for AlertMedia,” said Christopher Kenessey, CEO at AlertMedia.
  • Through his career, Ostryniec has held leadership positions at a variety of enterprise software companies, including Bazaarvoice, TATA Consultancy Services, and Trilogy.

Capital Rx's JUDI® Redefines the Role Technology Plays in the Administration of Medicare, Medicaid, and Commercial Pharmacy Programs

Retrieved on: 
Friday, October 6, 2023
CSID, Frustration, PBM, COVID, Feature, API, Health, Entrepreneurship, Medicare, PBA, Architecture, PAT, Physician, EHP, Health insurance, Cryptocurrency, Medicaid

With every core PBM function in JUDI® and the ability to rapidly deploy enhancements, clients save time and money.

Key Points: 
  • With every core PBM function in JUDI® and the ability to rapidly deploy enhancements, clients save time and money.
  • Launched in 2021 to improve costs and service levels in the commercial space, JUDI began processing Medicare claims on January 1, 2023.
  • This is another time-saving workflow enhancement that reduces the potential for errors and alleviates stress for health plan executives.
  • To learn more about Capital Rx's pharmacy benefit administration capabilities and JUDI, please visit Capital Rx – JUDI® .

STOP the Persecution of Political Leaders & Prisoners in TUNISIA

Retrieved on: 
Friday, September 29, 2023
National Press Club (United States), Press club, Islam, Multimedia, CSID, 13th Floor

WASHINGTON, Sept. 29, 2023 /PRNewswire/ -- Today, two of the leading opposition members in Tunisia, Sheikh Rached Ghannouchi and Mr. Jaouhar Ben Mbarek, announced that they have started a:

Key Points: 
  • WASHINGTON, Sept. 29, 2023 /PRNewswire/ -- Today, two of the leading opposition members in Tunisia, Sheikh Rached Ghannouchi and Mr. Jaouhar Ben Mbarek, announced that they have started a:
    to denounce their and their colleagues arrest without charges for the past 6-8 months and to demand their immediate release.
  • The human rights situation in Tunisia continues to worsen every day.
  • To address these terrible and worsening conditions, the Center for the Study of Islam & Democracy (CSID) is organizing a PRESS CONFERENCE with 4 leading Tunisian democracy and human rights activists:
    On Monday, October 2, 2023 (2:00-3:30 PM EDT) at: the National Press Club, First Amendment Lounge, 529 14th St. NW, 13th Floor, Washington, DC 20045
    For questions or further information, please contact Dr. Radwan A. Masmoudi at (202) 304-2940
    View original content to download multimedia: https://www.prnewswire.com/news-releases/stop-the-persecution-of-politic...

Intoleran's Quatrase Forte Is the Swiss Army Knife of Digestive Enzymes

Retrieved on: 
Wednesday, May 24, 2023
Carbohydrate, Glucan 1,4-a-glucosidase, Enzyme, Xylose isomerase, Eating, FODMAP, Sucrose, Fructose, CSID, IBS, Lactose intolerance, Food intolerance, Invertase, Digestion, Animal feed

FORT LAUDERDALE, Fla., May 24, 2023 /PRNewswire/ -- Intoleran is a Dutch health brand that has spent years specializing in the creation of clean, effective digestive enzyme supplements. From smart sourcing to an immaculate in-house production process to minimal ingredients and no unnecessary fillers, the brand has perfected the art of aiding digestion.

Key Points: 
  • This has resulted in a portfolio of targeted digestive enzymes and digestive products.
  • However, it's Quatrase Forte that has become the brand's flagship product and one of Intoleran's best sellers over the years.
  • "Quatrase Forte brings the concept of comprehensive digestional support into one single product," explains Intoleran owner Harmen Treep, "It provides a mixture of four key digestive enzymes that can help address a host of different digestive dilemmas."
  • "The thing is, with digestive enzymes, you don't have to worry about ingesting something your body doesn't need.

World IBS Day April 19th: Raising Awareness and Reducing Stigma of Irritable Bowel Syndrome

Retrieved on: 
Tuesday, April 18, 2023
Education, Diarrhea, Friends, Irritable bowel syndrome, World Gastroenterology Organisation, Quality of life, Constipation, Birth defect, WGO, CSID, Abdominal pain, Patient, IBS, Bloating, Diagnosis, American College of Gastroenterology, American College, Courage, ACG, Organization, Tourism

TORONTO, April 18, 2023 /PRNewswire/ -- April 19th marks World IBS Day, an international day of awareness for those living with Irritable Bowel Syndrome (IBS). With the support of QOL Medical – CSID, this day is dedicated to raising awareness of the quality of life issues faced by those with IBS and to reduce the stigma surrounding the illness.

Key Points: 
  • TORONTO, April 18, 2023 /PRNewswire/ -- April 19th marks World IBS Day, an international day of awareness for those living with Irritable Bowel Syndrome (IBS).
  • World IBS Day is an opportunity to raise awareness of the condition and to reduce the stigma associated with it.
  • Organizations around the world are taking part in World IBS Day by hosting events, sharing stories, and providing resources to those living with IBS.
  • For more information about World IBS Day and how to get involved, please visit www.worldibsday.org .

Prokeep Enlists Top National Talent to Board & VP Positions Preparing for Growth and Product Expansion in 2023

Retrieved on: 
Wednesday, December 14, 2022
Commerce, Culture, Communication, Software as a service, Austin, Texas, SVP, Procore, Growth, Level set, Marketing, Scott, CSID, Construction, Management, Online shopping, Video game, Experian

"Prokeep is growing fast to deliver even more value to distributors in 2023," said Prokeep CEO, Jack Carrere.

Key Points: 
  • "Prokeep is growing fast to deliver even more value to distributors in 2023," said Prokeep CEO, Jack Carrere.
  • Prokeep is an innovative technology company developing modern ways for distributors to connect to customers with efficiency and ease.
  • By pioneering how branches communicate with customers through messaging, Prokeep revolutionized the way distributors make sales.
  • Since its founding in 2016, Prokeep has seen exponential growth in its customer base (1,000+ distributors), staff, and product development.

QOL Medical, LLC receives FDA approval of Sucraid® (sacrosidase) Oral Solution single-use containers for patients with Congenital Sucrase-Isomaltase Deficiency (CSID)

Retrieved on: 
Tuesday, September 6, 2022
Tao, People, COO, Food and Drug Administration, Diarrhea, Vegetable, Degenerative disease, Swelling, Sucrose, Doctor of Philosophy, Starch, Temperature, Sucrose intolerance, Nervous, NEVER, Headache, Diet, CSID, Quality of life, Irritable bowel syndrome, Abdominal pain, Constipation, Absorption, Dehydration, MD, Digestion, Birth defect, FDA, Irritability, Allergy, Vomiting, Failure, LLC, IBS, Enzyme replacement therapy, Glycerol, Blood, Seborrhoeic dermatitis, Diabetes, Papain, Acquisition, Sugar, Light, Nausea, Patient, Pharmaceutical industry, Dietary supplement, Dairy product, Sacrosidase

Now Sucraid is available in both Sucraid multi-dose bottles and Sucraid single-use containers.

Key Points: 
  • Now Sucraid is available in both Sucraid multi-dose bottles and Sucraid single-use containers.
  • These new single-use containers will make it easier for them to manage their medication," said Weng Tao, MD, PhD, COO of QOL Medical, LLC.
  • "FDA's approval of Sucraid single-use containers, with three-day room temperature stability, offer greater convenience for CSID patients on the go."
  • Sucraid(sacrosidase) Oral Solution is an enzyme replacement therapy for the treatment of genetically determined sucrase deficiency, which is part of congenital sucrase-isomaltase deficiency (CSID).

Intoleran Uses Digestive Enzymes to Manage Starch and Sucrose Intolerance

Retrieved on: 
Monday, August 29, 2022
Enzyme, Food, Glucan 1,4-a-glucosidase, Fructose, Galactose, Eating, Starch, Invertase, Food allergy, Diet, CSID, Lactose, Immune system, Sucrose, Fructan, Human, Feed manufacturing, Dairy product

FORT LAUDERDALE, Fla., Aug. 29, 2022 /PRNewswire/ -- Intoleran has a reputation as a company that enables people to enjoy food again. This comes from the Dutch health brand's range of digestive enzyme products, which help its customers manage food intolerances.

Key Points: 
  • This comes from the Dutch health brand's range of digestive enzyme products, which help its customers manage food intolerances.
  • They occur when the body cannot create enough of a particular digestive enzyme to break down the food that an individual consumes.
  • In the case of starch and sucrose intolerance, the body doesn't create enough of the enzyme sucrase-isomaltase .
  • There are multiple ways to address a lack of enzymes to break down starch and sucrose.

QOL Medical, LLC Selects Optum Frontier Therapies as an Exclusive Pharmacy Partner to Best Support Congenital Sucrase-Isomaltase Deficiency (CSID) Patients on Sucraid® (sacrosidase) Oral Solution

Retrieved on: 
Friday, April 15, 2022
Tao, People, IBS, Allergy, Seborrhoeic dermatitis, Papain, LLC, Blood, NEVER, Degenerative disease, Nervous, Sugar, MD, Glycerol, Dehydration, Patient, Ice cream, Birth defect, COO, Bloating, Light, Pharmacy, Diet, Failure, CSID, Irritable bowel syndrome, Enzyme replacement therapy, Headache, General manager, Irritability, Sucrose intolerance, Absorption, Diabetes, Constipation, FDA, Quality of life, Digestion, Attention, Vomiting, Acquisition, Abdominal pain, Diarrhea, Nausea, Swelling, Starch, Pharmaceutical industry, Dietary supplement, Hospital, Dairy product, Sacrosidase, Sucrose

QOL Medical, LLC Selects Optum Frontier Therapies as an Exclusive Pharmacy Partner to Support CSID patients nationwide.

Key Points: 
  • QOL Medical, LLC Selects Optum Frontier Therapies as an Exclusive Pharmacy Partner to Support CSID patients nationwide.
  • Sucraid(sacrosidase) Oral Solution is an enzyme replacement therapy for the treatment of genetically determined sucrase deficiency, which is part of Congenital Sucrase-Isomaltase Deficiency.
  • "The migration to Optum Frontier Therapies means better care for our patients, and greater attention and support for our healthcare providers."
  • Their patient-first pharmacy model is designed to simplify the patient's experience by providing one-on-one expert guidance for their pharmacy needs.

Food Sensitivity Symptoms May Be Caused by Sucrose Intolerance: Fourth Annual National Sucrose Intolerance Awareness Week April 11-17, 2022

Retrieved on: 
Tuesday, April 12, 2022
Awareness, Vegetable, LLC, Eating, Education, Ice cream, Patient, Birth defect, CSID, Sucrose, Food intolerance, Marketing, Starch, Dairy product

VERO BEACH, Fla., April 12, 2022 /PRNewswire/ -- QOL Medical, LLC today announced their theme for the 4th annual National Sucrose Intolerance Awareness Week, from April 11-17, 2022.

Key Points: 
  • VERO BEACH, Fla., April 12, 2022 /PRNewswire/ -- QOL Medical, LLC today announced their theme for the 4th annual National Sucrose Intolerance Awareness Week, from April 11-17, 2022.
  • was selected based on one of the top Goggled questions in the food intolerance and allergy category.
  • National Sucrose Intolerance Awareness Week: April 11-17th 2022
    This week has been established to raise awareness about the unmet needs of people suffering from symptoms due to an inability to digest sucrose (table sugar).
  • Sucrose Intolerance caused by CSID is a chronic medical condition, affecting infants, teens, and adults.